IS8219A - Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun - Google Patents

Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun

Info

Publication number: IS8219A
Authority: IS; Iceland
Prior art keywords: preparation; preparations containing; benzimidazole derivatives; benzimidazole; derivatives
Prior art date: 2003-06-10

Application number

IS8219A

Other languages

English (en)

Inventor

Liu Ziping

Pagè Daniel

Walpole Christopher

Yang Hua

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-10

Filing date

2006-01-04

Publication date

2006-01-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29212435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8219(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-01-04 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2006-01-04 Publication of IS8219A publication Critical patent/IS8219A/is

Links

238000002360 preparation method Methods 0.000 title 2
229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

IS8219A 2003-06-10 2006-01-04 Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun IS8219A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0301701A SE0301701D0 (sv)	2003-06-10	2003-06-10	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
PCT/GB2004/002430 WO2004108712A1 (en)	2003-06-10	2004-06-09	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Publications (1)

Publication Number	Publication Date
IS8219A true IS8219A (is)	2006-01-04

Family

ID=29212435

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS8219A IS8219A (is)	2003-06-10	2006-01-04	Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun

Country Status (19)

Country	Link
US (2)	US7501447B2 (is)
EP (1)	EP1636214A1 (is)
JP (1)	JP2006527249A (is)
KR (1)	KR20060018258A (is)
CN (1)	CN100455580C (is)
AR (1)	AR044666A1 (is)
AU (1)	AU2004245298A1 (is)
BR (1)	BRPI0411246A (is)
CA (1)	CA2528925A1 (is)
CO (1)	CO5660260A2 (is)
IL (1)	IL172023A0 (is)
IS (1)	IS8219A (is)
NO (1)	NO20060147L (is)
RU (1)	RU2005138366A (is)
SE (1)	SE0301701D0 (is)
TW (1)	TW200504029A (is)
UY (1)	UY28356A1 (is)
WO (1)	WO2004108712A1 (is)
ZA (1)	ZA200509863B (is)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0301446D0 (sv) *	2003-05-16	2003-05-16	Astrazeneca Ab	New Compounds
SE0302570D0 (sv) *	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302573D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2006033629A1 (en) *	2004-09-24	2006-03-30	Astrazeneca Ab	Benzimidazole derivatives and their use as cannabinoid receptor ligands
ES2380709T3 (es)	2004-09-24	2012-05-17	Astrazeneca Ab	Derivados de bencimidazol, composiciones que los contienen, su preparación y usos
WO2006033630A1 (en) *	2004-09-24	2006-03-30	Astrazeneca Ab	Compounds, compositions containing them, preparation thereof and uses thereof iii
EP1797076A1 (en) *	2004-09-24	2007-06-20	AstraZeneca AB	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
EP1797077B1 (en) *	2004-09-24	2012-02-15	AstraZeneca AB	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
CN101031563A (zh) *	2004-09-24	2007-09-05	阿斯利康(瑞典)有限公司	苯并咪唑衍生物、含有它们的组合物、其制备方法和用途
WO2006033632A1 (en) *	2004-09-24	2006-03-30	Astrazeneca Ab	Benzimidazole derivatives and their use as cannabinoid receptor ligands I
CA2585030A1 (en)	2004-10-27	2006-05-04	F. Hoffmann-La Roche Ag	New indole or benzimidazole derivatives
WO2007024294A2 (en) *	2005-05-03	2007-03-01	Cgi Pharmaceuticals, Inc.	Certain substituted ureas, as modulators of kinase activity
TW200736227A (en) *	2005-12-23	2007-10-01	Astrazeneca Ab	New compounds III
TW200745049A (en)	2006-03-23	2007-12-16	Astrazeneca Ab	New crystalline forms
TW200808769A (en)	2006-04-18	2008-02-16	Astrazeneca Ab	Therapeutic compounds
TWI433839B (zh) *	2006-08-11	2014-04-11	Neomed Inst	新穎的苯并咪唑衍生物290
ES2960991T3 (es)	2014-09-12	2024-03-07	Biohaven Therapeutics Ltd	Benzoimidazol-1,2-ilamidas como activadores del canal Kv7
CN118955400A (zh)	2018-03-19	2024-11-15	诺普生物科学有限责任公司	Kv7通道激活剂组合物和使用方法
WO2023166450A1 (ko) *	2022-03-04	2023-09-07	삼진제약주식회사	신규한 헤테로 고리 화합물 및 이를 포함하는 약학적 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE793718A (fr) *	1972-01-07	1973-07-05	Merck & Co Inc	Aminobenzimidazoles
HUP9900625A3 (en) *	1995-12-28	2003-04-28	Fujisawa Pharmaceutical Co	Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds
JP2000095767A (ja) *	1998-09-28	2000-04-04	Takeda Chem Ind Ltd	性腺刺激ホルモン放出ホルモン拮抗剤
FR2789079B3 (fr) *	1999-02-01	2001-03-02	Sanofi Synthelabo	Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
SE0101387D0 (sv)	2001-04-20	2001-04-20	Astrazeneca Ab	Novel compounds
TWI231757B (en)	2001-09-21	2005-05-01	Solvay Pharm Bv	1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
SE0203070D0 (en) *	2002-10-16	2002-10-16	Astrazeneca Ab	Novel compounds
SE0301698D0 (sv) *	2003-06-10	2003-06-10	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

2003
- 2003-06-10 SE SE0301701A patent/SE0301701D0/xx unknown
2004
- 2004-06-09 WO PCT/GB2004/002430 patent/WO2004108712A1/en not_active Ceased
- 2004-06-09 US US10/557,806 patent/US7501447B2/en not_active Expired - Fee Related
- 2004-06-09 AU AU2004245298A patent/AU2004245298A1/en not_active Abandoned
- 2004-06-09 EP EP04736412A patent/EP1636214A1/en not_active Withdrawn
- 2004-06-09 RU RU2005138366/04A patent/RU2005138366A/ru not_active Application Discontinuation
- 2004-06-09 JP JP2006516386A patent/JP2006527249A/ja active Pending
- 2004-06-09 CA CA002528925A patent/CA2528925A1/en not_active Abandoned
- 2004-06-09 CN CNB2004800163234A patent/CN100455580C/zh not_active Expired - Fee Related
- 2004-06-09 BR BRPI0411246-6A patent/BRPI0411246A/pt not_active IP Right Cessation
- 2004-06-09 KR KR1020057023713A patent/KR20060018258A/ko not_active Withdrawn
- 2004-06-10 UY UY28356A patent/UY28356A1/es not_active Application Discontinuation
- 2004-06-10 AR ARP040102017A patent/AR044666A1/es not_active Application Discontinuation
- 2004-06-10 TW TW093116689A patent/TW200504029A/zh unknown
2005
- 2005-11-17 IL IL172023A patent/IL172023A0/en unknown
- 2005-12-05 ZA ZA200509863A patent/ZA200509863B/en unknown
- 2005-12-05 CO CO05123380A patent/CO5660260A2/es not_active Application Discontinuation
2006
- 2006-01-04 IS IS8219A patent/IS8219A/is unknown
- 2006-01-10 NO NO20060147A patent/NO20060147L/no not_active Application Discontinuation
2009
- 2009-01-08 US US12/350,322 patent/US20090111865A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004108712A1 (en)	2004-12-16
JP2006527249A (ja)	2006-11-30
AR044666A1 (es)	2005-09-21
SE0301701D0 (sv)	2003-06-10
BRPI0411246A (pt)	2006-07-18
IL172023A0 (en)	2009-02-11
UY28356A1 (es)	2005-01-31
AU2004245298A1 (en)	2004-12-16
KR20060018258A (ko)	2006-02-28
TW200504029A (en)	2005-02-01
CN100455580C (zh)	2009-01-28
US7501447B2 (en)	2009-03-10
EP1636214A1 (en)	2006-03-22
NO20060147L (no)	2006-03-07
US20090111865A1 (en)	2009-04-30
RU2005138366A (ru)	2006-07-27
CO5660260A2 (es)	2006-07-31
CN1805956A (zh)	2006-07-19
US20060205802A1 (en)	2006-09-14
ZA200509863B (en)	2006-12-27
CA2528925A1 (en)	2004-12-16

Publication	Publication Date	Title
IS8422A (is)	2006-04-21	Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra
DK1673349T3 (da)	2010-10-25	Benzimidazolderivater: fremstilling og farmaceutiske anvendelser
IS6661A (is)	2002-12-19	Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun
IS8219A (is)	2006-01-04	Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun
IS7079A (is)	2003-12-15	Fenýlsúlfónýl-1,3-díhýdró-2H-indól-2-ón afleiður,framleiðsla þeirra og notkun í meðferðarskyni
IL177533A (en)	2010-12-30	Benzimidazole derivatives, their preparation and pharmaceutical compositions comprising them
IS2458B (is)	2008-11-15	Indólín-2-ón afleiður, framleiðsla og notkun þeirra sem mjaltavaka (ocytocin) viðtakabindlar
DK1511734T3 (da)	2010-08-02	Forbindelser, præparater og fremgangsmåder
IS7491A (is)	2004-10-06	Benzoxazínon-afleidd efnasambönd, framleiðsla þeirra og notkun sem lyf
DK1095025T3 (da)	2003-04-07	Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
DK1513836T3 (da)	2006-09-11	Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1590321T3 (da)	2010-08-09	Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
IS8220A (is)	2006-01-04	Bensímídasólafleiður, blöndur sem innihalda þær, framleiðsla þeirra og notkun
DK1334106T3 (da)	2006-09-18	Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
DK1417189T3 (da)	2006-05-08	Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1556382T3 (da)	2008-10-06	3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
IS7798A (is)	2005-04-11	Efnasambönd, lyfjablöndur og aðferðir
NO20053809D0 (no)	2005-08-12	Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
SI1673349T1 (sl)	2010-10-29	Derivati benzimidazola: priprava in farmacevtske uporabe
NO20033120D0 (no)	2003-07-08	2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
DK1773829T3 (da)	2009-04-20	Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf
NO20053805D0 (no)	2005-08-12	Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
DK1791872T3 (da)	2009-05-04	Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf
NO20055142D0 (no)	2005-11-02	Diarylmetylidenpiperidinderivater, fremstillinger og anvendelser derav
DK1781631T3 (da)	2012-05-14	Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf